# PALIPERIDONE
> **ANDA216174** · Abbreviated New Drug Application (Generic) · Sponsor: ASCENT PHARMS INC · Approved 2023-08-23
## Drug
- **FDA Application Number:** ANDA216174
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PALIPERIDONE
- **Generic name:** PALIPERIDONE
- **Active ingredients:** PALIPERIDONE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASCENT PHARMS INC
- **Manufacturer:** Camber Pharmaceuticals, Inc
- **First approval:** 2023-08-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216174)
---
*MORVS · CC0 1.0*